Navigation Links
L3 Healthcare’s Clinical Trials Division Becomes Certified Designer for iMedNet eClinical and Electronic Data Management Software
Date:4/25/2017

L3 Clinical Trials, the Clinical Research Organization (CRO) division of L3 Healthcare, is pleased to announce the company is now a certified iMedNet eClinical and Electronic Data Capture software designer for clinical trial data management. The iMedNet software certification enables the company’s clinical research team to build, customize and manage clinical trial data capture and databases for clients. In completing this certification, L3 Clinical Trials, continues to provide an integrated and comprehensive suite of services that can support an entire clinical trial program: from study concept to data analysis, reporting, and site level payments.

“A fully integrated clinical research organization that has the expertise, know-how and streamlined approach helps customers conduct clinical trials efficiently and cost-effectively,” said Chermaen Lindberg, Partner at L3 Healthcare. “Our certification allows us to manage all aspects of a clinical trial, obviating the need to utilize additional data management resources, apply add-ons, or subcontract with 3rd party data management vendors.” By eliminating these common but unnecessary complexities, L3 Clinical Trials is uniquely positioned to provide clients with premium services at the most affordable industry rates.

The L3 Clinical Trials’ business model is based on providing start-ups and mid-size in vitro diagnostic (IVD) and medical device companies with highly experienced resources that intuitively and effectively function as part of their clients’ project teams. In obtaining the certification through iMedNet, L3 Clinical Trials reinforces its integrated and collaborative approach with consistent staff resources throughout the process, fostering the best possible environment and identifying cost-effective clinical trial solutions.

“We pursued iMedNet certification so that we can deliver several unique and time-saving steps for our sites and our sponsors, such as the ability to access and use the system on multiple platforms and provide electronic-entry adjudication capability,” said Jane Edwards, VP Clinical Research at L3 Healthcare. “By streamlining the process and providing the most advanced technology, we can provide yet another solution for simplifying the integration of electronic data capture (EDC) into clinical studies. This improves workflow for clinicians and research coordinators while helping contain costs.”

About L3 Healthcare
L3 Healthcare, founded by IVD and medical device professionals, provides proven pre- and post-market expertise and resources dedicated to assisting organizations with generating clinical evidence, establishing clinical value and increasing market adoption in the global marketplace. L3 Clinical Trials, a division of L3 Healthcare, focuses its services on devising and executing clinical trials through streamlined processes, staff, technology and its vast key opinion leader and research network in the biotech and life science industries. The L3 Clinical Trials team understands the importance of strategically approaching clinical trials and go-to-market projects in environments with limited funds and resources, and seamlessly fills in the gaps where needed to achieve the desired goals. L3 specializes in key disease states and global markets that help provide value and a distinct edge for its clients. For more information, visit http://www.L3clinicaltrials.com.

About iMedNet
MedNet Solutions is a leading healthcare technology company specializing in electronic data solutions designed for the global life sciences community. MedNet’s proven, flexible and easy-to-use cloud-based eClinical systems dramatically improve the efficiency of clinical studies and registries of all types and sizes. Beyond simply electronic data capture (EDC), MedNet’s solutions deliver the tools and dashboards required to expertly manage all aspects of clinical research. Since 2001, pharmaceutical, medical device, biotechnology and Contract Research Organizations (CROs) around the world have trusted MedNet to consistently deliver the technology innovation, experience and reliability they need for success. For more information, please visit http://www.mednetsolutions.com/

Read the full story at http://www.prweb.com/releases/2017/04/prweb14269186.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Parallel6 Named One of the 2017 Top 10 eClinical Trial Management Solution Providers by Pharma Tech Outlook
2. Nobilis Therapeutics Announces Completion of Landmark NBTX-001 Clinical Trial in 81 Patients with Panic Disorder
3. First Published Clinical Study Successfully Uses Precision Medicine To Predict Prescription Opioid Abuse
4. Multi-Center Clinical Study Confirms Decreased Levels of Procalcitonin as an Independent Predictor of Mortality in Patients with Severe Sepsis and Septic Shock
5. Benchmark Research/VaxCorps Named one of the Top Clinical Research Networks at ViE Awards
6. SimpleTrials Selected as a Top 10 eClinical Trial Management Solution Provider by Pharma Tech Outlook
7. Human Gene Therapy publishes review of randomized clinical trials of gene transfer for heart failure with reduced ejection fraction
8. 2-Day Seminar FDAs GMP Expectations for Phase I and First-in-Man Clinical Trials by Ex-FDA Official (Tampa, FL, United States - May 18-19, 2017) - Research and Markets
9. Keystone Nano Announces Start Of Clinical Testing Of Ceramide NanoLiposome For The Improved Treatment Of Cancer
10. Research Centers of America Adopts Verified Clinical Trials Biometrics Research Subject Database Registry to Prevent Duplicate Enrollment in Clinical Trials
11. Nektar Therapeutics Presents New Preclinical Data for its Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... May 23, 2017 , ... Genedata, ... 20th anniversary, marking the occasion with a strong presence at Bio-IT World Conference ... and further extends an invitation to all attendees to view posters on ...
(Date:5/23/2017)... ... May 23, 2017 , ... Vortex Biosciences , provider of circulating tumor ... circulating tumor cells using Vortex microfluidic technology ” in Nature Precision Oncology on May ... Dino Di Carlo and Dr. Matthew Rettig at the University of California, Los Angeles. ...
(Date:5/23/2017)... Diego, CA (PRWEB) , ... May 23, 2017 , ... ... matrix of polymeric molecules, can cause diverse pathologies ranging from food poisoning and catheter ... impact of biofilms is in the tens of billions of dollars per year, there ...
(Date:5/22/2017)... ... May 22, 2017 , ... Stratevi, a boutique firm that partners with healthcare ... has opened an office in downtown Boston at 745 Atlantic Ave. , “We ... to generate evidence on the value they provide, not just to patients, but also ...
Breaking Biology Technology:
(Date:3/22/2017)... 21, 2017 Optimove , provider ... retailers such as 1-800-Flowers and AdoreMe, today announced ... and Replenishment. Using Optimove,s machine learning algorithms, these ... and replenishment recommendations to their customers based not ... of customer intent drawn from a complex web ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela Merkel visited ... to the DERMALOG stand together with the Japanese Prime Minster Shinzo Abe. ... the largest German biometrics company the two government leaders could see the ... well as DERMALOG´s multi-biometrics system.   Continue Reading ... ...
(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in Germany ... ... one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification Systems) ... Used combined in one project, multi-biometric solutions provide a crucial contribution ... ...
Breaking Biology News(10 mins):